Synthesis, in vitro metabolism, mutagenicity, and DNA-adduction of naphtho[1,2-e]pyrene

Polycyclic Aromatic Compounds

Volumn 22, Issue 3-4, 2002, Pages 267-276

  Desai, Dhimant ^a   Sharma, Arun K ^a   Lin, Jyh Ming ^a   El Bayoumy, Karam ^a   Amin, Shantu ^a   Pimentel, Maria ^b   Nesnow, Stephen ^b  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cell transformation; DNA adducts; Metabolism; Mutagenicity; Naphtho 1,2 e pyrene; Synthesis

Indexed keywords

BIOACTIVITY; BIOMOLECULES; DNA; ISOMERS; MAMMALS; METABOLITES; MUTAGENESIS; PHYSIOLOGY; PYRENE;

CELL TRANSFORMATION; DNA ADDUCTS; ENVIRONMENTAL SAMPLE; IN-VITRO; LITERATURE DATA; MUTAGENICITY; NAPHTHO[1,2-E]PYRENE; SUZUKI REACTION; SYNTHESISED; Β-NAPHTHOFLAVONE;

METABOLISM;

11,12 DIHYDROXY 11,12 DIHYDRONAPHTHO[1,2 E]PYRENE; ADENINE; BETA NAPHTHOFLAVONE; DNA; EPOXIDE; NAPHTHO[1,2 E]PYRENE; NAPHTHO[1,2 E]PYRENE 11,12 DIOL 13,14 EPOXIDE; PHENOBARBITAL; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; BACTERIAL STRAIN; CELL STRUCTURE; CELL TRANSFORMATION; CHEMICAL REACTION; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; IN VITRO STUDY; ISOMER; LIVER HOMOGENATE; MAMMAL CELL; METABOLITE; MOUSE; MUTAGENICITY; NONHUMAN; SALMONELLA TYPHIMURIUM; SUZUKI REACTION; SYNTHESIS;

EID: 0036025798     PISSN: 10406638     EISSN: None     Source Type: Journal    
DOI: 10.1080/10406630290026911     Document Type: Conference Paper

References (14)

1. E. L. Cavalieri, S. Higginbotham, N. V. S. Ramakrishna, P. D. Devanesan, R. Todorovic, E. G. Rogan, and S. Salmasi, Carcinogenesis 12 (1991):1939.
2. E. L. Cavalieri, E. G. Rogan, S. Higginbotham, P. Cremonesi, and S. Salmasi, J. Cancer Res. Clin. Oncol. 115 (1989):67.
3. G. W. Handricks, E. C. Attane, and J. W. Wilson, United States Patent 3,619,407 (1971).
4. A. Lacassagne, N. P. Buu-Hoi, and F. Zajdela, CR Acad. Sci. 250 (1960):2728.
5. A. Dipple, R. C. Mehta, and C. A. H. Bigger, "Polycyclic Aromatic Hydrocarbons," in Chemical Carcinogens, ed. C. E. Searle, ACS Monograph 182 (Washington, D.C.: American Chemical Society, 1984).
6. D. Desai, M. Pimentel, J. Krzeminski, K. El-Bayoumy, S. Nesnow, and S. Amin, in Proceedings of American Association for Cancer Research, no. 859, New Orleans, La. (2001).
7. A. K. Sharma, J. Krzeminski, D. Desai, and S. Amin, in Proceedings of 18th ISPAC, no. 142, Cincinnati, Ohio (2001).
8. D. Desai, J. Krzeminski, J. M. Lin, A. Chadha, N. Miyata, H. Yagi, D. M. Jerina, and S. Amin, Polycyclic Aromatic Compounds 16 (1999):255.
9. D. M. Maron and B. N. Ames, Mutat. Res. 113 (1983):173.
10. S. Nesnow, C. Davis, W. T. Padgett, L. Adams, M. Yacopucci, and L. C. King, Carcinogenesis 211 (2000):1253.
11. C. Reznikoff, J. S. Bertram, D. W. Brankow, and C. Heidelberger, Cancer Res. 33 (1973):3239.
12. J. M. Lin, D. Desai, L. Chung, S. S. Hecht, and S. Amin, Chem. Res. Toxicol. 12 (1999):341.
13. S. K. Agarwal, J. M. Sayer, H. J. C. Yeh, L. K. Pannell, B. D. Hilton, M. A. Pigott, A. H. Dipple, H. Yagi, and D. M. Jerina, J. Am. Chem. Soc. 109 (1987):2497.
14. H. J. Einhoff, S. Amin, H. Yagi, D. M. Jerina, and W. M. Baird, Carcinogenesis 17 (1996):2244.